Realcan Pharmaceutical Group Co Ltd
002589
Company Profile
Business description
Realcan Pharmaceutical Group Co Ltd is a Chinese company engaged in direct pharmaceuticals distribution services. The company's main business is divided into the Drug, vaccine, medical device circulation service; Medical industry third-party logistics; Medical information service; Medical logistics service; Chinese medicine plate; Hospital management sector; Medical industry research and development production sector; and Medical industry financial sector.
Contact
No. 326, Airport Road
Zhifu District, Shandong Province
Yantai264004
CHNT: +86 5356735656
Sector
Healthcare
Stock type
Defensive
Industry
Medical Distribution
Fiscal Year End
31 December 2025
Employees
2,897
Stocks News & Analysis
stocks
10 best US dividend aristocrats to buy now—including a surprise outperformer
These undervalued stocks with wide and narrow moats have increased their dividends for 25 consecutive years or more.
stocks
Leading ASX players in this field look materially overvalued
We raise our Fair Value estimates but still think that current share prices rely on overly optimistic expectations.
stocks
After earnings, is Alphabet stock a buy, a sell, or fairly valued?
With a diverse portfolio of innovative technology and integrated media platforms, here’s what we think of Alphabet’s stock.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,995.80 | 19.60 | -0.22% |
CAC 40 | 7,861.96 | 4.60 | 0.06% |
DAX 40 | 24,262.22 | 44.85 | 0.19% |
Dow JONES (US) | 44,461.28 | 171.71 | -0.38% |
FTSE 100 | 9,136.94 | 0.62 | 0.01% |
HKSE | 24,799.91 | 377.02 | -1.50% |
NASDAQ | 21,129.67 | 31.38 | 0.15% |
Nikkei 225 | 41,102.12 | 447.42 | 1.10% |
NZX 50 Index | 12,823.74 | 32.23 | -0.25% |
S&P 500 | 6,362.90 | 7.96 | -0.12% |
S&P/ASX 200 | 8,740.20 | 16.20 | -0.19% |
SSE Composite Index | 3,580.98 | 34.73 | -0.96% |